HCI Opportunities

wdt_ID wdt_created_by wdt_created_at wdt_last_edited_by wdt_last_edited_at Name of Funding Organization Focus Area Purpose Funding Size Eligibility Criteria Website Contact Closing Date Funding Cycle Funding Mechanism Eligible Recipients Florida Resident Required Nonprofit Required Small Business Required Early Stage Funding U.S. Ownership Required Type of Funding
1 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM AbbVie Ventures AbbVie All Innovation Focused on exclusively on novel, transformational therapeutics at discovery and pre-clinical stages. Aligning with AbbVie's strategic focus, the investments address critical needs in oncology, immunology, neuroscience, eye care, and aesthetics. Offering partners access to AbbVie's vast internal network of experts in all phases of drug development, from drug discovery through successful commercialization. Eligibility criteria includes transformational scientific opportunities aligned with AbbVie Ventures' core R&D interests (Immunology, Oncology, Neuroscience, Eye Care, Aesthetics, Virology, Cystic Fibrosis, Women's Health, & Platform and Technologies) abbvieventures@abbvie.com Recurring Equity Financing Individuals No No No No Not Specified Private
2 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Accelerator Course - Epilepsy Foundation Epilepsy Foundation Improving Patient Outcomes The Epilepsy Foundation, in partnership with the Danny Did Foundation conducts the Accelerator course, which is a six-week virtual course is designed for startup companies focused on improving the lives of people living with epilepsy. Each week for six weeks beginning in the spring of 2024, the Epilepsy Foundation will bring in featured experts in epilepsy and successful Individuals. Each expert will provide participants selected for the program with multiple perspectives and considerations to commercialize a venture. The applicants must be: 1. Be developing a device, technology, or digital health tool designed for people with epilepsy. 2. Applying as a business entity. A university may partner with an existing company through licensing to commercialize the venture and applicant should list the company in application. 3. Must demonstrate in the application an ability to move the proposed plan to completion, showing how an investment can accelerate a step along the path to market. 4. Applicants must submit a model/prototype of proposed project (must include demonstration of some form of materialization - i.e. early sample, model or release of a product built for testing). 5. Individuals who have previously received Epilepsy Foundation funding through Shark Tank Competitions or New Therapy Commercialization Grants are encouraged to re-submit their ideas if substantial progress has been made. 6. Applicants may reside in any country so long as they are committed to attending all lectures. research@efa.org Recurring Accelerator Individuals No No No Yes No Private
3 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Amber Grant Amber Foundation All Innovation Amber Grants are offered by WomensNet which offers grants for women in business on a monthly basis. Winners announced the following month on the 23rd. $10,000 Women-led startups or businesses info@ambergrantsforwomen.com Recurring Grant Individuals No No No No Yes Private
4 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Baxter Ventures Baxter International All Innovation Created in 2011 by Baxter International Inc., Baxter Ventures builds on the company's more than 85-year legacy of supporting healthcare innovation and saving and sustaining lives worldwide. Baxter Ventures' investment focus includes therapeutic areas complementary to Baxter's presence in critical, hospital, nutritional, renal and surgical care, as well as cutting-edge technology and therapies outside of Baxter's current product portfolio. Baxter Ventures invests in companies with innovative technologies, products, and therapies that accelerate growth and advance patient care. Each investment opportunity undergoes a rigorous evaluation process to determine if it has the potential to address unmet clinical needs and offer sustainable long-term growth. Areas of Interest Include: In-Hospital Solutions and Therapeutics Critical Care Surgical Care Medical Devices Monitoring and Diagnostic Tools Medication Delivery and Management Pharmacy Technology Tools Renal Therapies Healthcare Information Technology Ventures@baxter.com Recurring Equity Financing Individuals No No No No Not Specified Private
5 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Black Business Loan Program Florida Department of Commerce All Innovation The Black Business Loan Program provides loans, loan guarantees, or investments through Loan Administrators to black business enterprises that cannot otherwise obtain capital through conventional lending institutions but who could otherwise compete successfully in the private sector. Up to $250,000 51% black-owned Domiciled in the state of Florida, active registration with Sunbiz United States Citizen or Lawful Permanent Residence For profit business, sole proprietorship. No non-profits. Must demonstrate that loans will aid in the generation of jobs Must use funds for working capital, inventory, equipment Collateral will be required in most cases. Applicant(s) will be the guarantor(s) Personal credit history will be used as part of the underwriting process to evaluate all loans. bblploans@famufcu.com Recurring Loan/Loan Guarantee Individuals Yes No Yes No Yes State
6 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 03:27 PM Blue Venture Fund Blue Cross Blue Shield All Innovation Focused on long-term strategic partnerships, we emphasize relationship building and focus on helping Individuals. up to $20 million The Funds invest in venture and growth opportunities within health care technology, health care services and clinical sciences. Recurring Equity Financing Individuals No No No No Not Specified Private
7 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 03:25 PM Coccidioidomycosis Collaborative Research Centers National Institutes of Health Health To assist public and private nonprofit institutions and individuals to establish, expand and improve biomedical research and research training in infectious diseases and related areas; to conduct developmental research, to produce and test research materials. To assist public, private and commercial institutions to conduct developmental research, to produce and test research materials, to provide research services as required by the agency for programs in infectious diseases, and controlling disease caused by infectious or parasitic agents, allergic and immunologic diseases and related areas. Projects range from studies of microbial physiology and antigenic structure to collaborative trials of experimental drugs and vaccines, mechanisms of resistance to antibiotics as well as research dealing with epidemiological observations in hospitalized patients or community populations and progress in allergic and immunologic diseases. up to $1.2 million Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. CoccidioidomycosisResearchCenters@mail.nih.gov 07/10/2026 No No No Yes Federal
8 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 03:20 PM Boston Scientific Ventures Boston Scientific All Innovation Boston Scientific Ventures investments span the globe and all company stages and invest in companies that are developing innovative medical solutions to improve outcomes, increase efficiencies, and serve patients connected to Boston Scientific's Businesses. Boston Scientific has invested over $1B in more than 60 portfolio companies since 2012 and has over 35 active portfolio companies ranging from early-stage research and development through commercialization. Companies that are developing innovative medical solutions to improve outcomes, increase efficiencies, and serve patients connected to Boston Scientific's Businesses. Recurring Equity Financing Organizations No No No No Not Specified Private
9 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Breakthrough Accelerator Breakthrough Accelerator Improving Patient Outcomes Breakthrough Accelerator supports teams as they test, refine, and scale youth-centered innovations that promote adolescent sexual and reproductive health. The approach combines human-centered design with equity-focused resources, training, and coaching. $100,000 Applicants are required to identify a three-person team. The diversity of skillsets and knowledge should be considered on the team, as well as end user representation. The team doesn't have to include people from different organizations, but should be able to articulate what unique skills and expertise each team member brings and demonstrate the ability to work together. breakthroughaccelerator@childtrends.org Recurring Accelerator No No No No Not Specified Private
10 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Build Stage Accelerator Starter Studio All Innovation For Individuals, once their idea is validated and have a thorough understanding of the customer base, it could be time to jump in build stage. This 10 week hybrid program helps the business to build early infrastructure and learn the value of customer acquisition (not initial reliance on outside capital) for early growth and sustainability of the business, develop a Minimum Viable Product, create a go-to-market strategy, acquire the first customer and revenue, define company culture, and so much more. This bootstrapping approach is increasingly overlooked as a means of success, but is the most important source of validation and ability to attract capital along a continuum of growth. By the end of the program, participants are targeted to achieve the following: - Establish the company that will deliver the solution to the problem they are solving - Develop an MVP (minimum viable product) or define a route to a prototype - Obtain first customer revenue (if you are a SaaS business) - Select a co-founder or founding team Applicants must complete the Build Stage Application - Applicants must complete a Zoom/in-person interview with a Starter Studio staff member - Applicants must complete payment of $995 by the start of the program - Minimum of one founder working full-time in the business - Have the following items completed and available: - Validated Problem/Solution Fit and clearly defined Value Proposition - Detailed Value Proposition Canvas - Effective Elevator Pitch - Bootstrapping Strategy - Self-assessments as required (e.g. 16 Personalities, etc.) - Commitment to attend all sessions and complete required assignments 2. This program may be the best fit for the applicants if they are: - Fully committed to establishing/growing a sustainable business - Working towards/have secured their first revenue customer - Working on developing an MVP or prototype (or have an initial version) - Ready to develop a comprehensive Go-To-Market strategy - Ready to learn about funding options info@starterstudio.org Recurring Accelerator Individuals Yes No No Yes Not Specified Private
11 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) National Institutes of Health Improving Patient Outcomes To support investigator-initiated clinical trials related to the programmatic interests of the NCI Division of Cancer Prevention and/or the NCI Division of Cancer Control and Population Sciences that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer; with such attributes, the proposed studies should also have the potential to improve clinical practice and/or public health. Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISIs) Nonprofits Other Than Institutions of Higher Education Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit Organizations Small Businesses For-Profit Organizations (Other than Small Businesses) Local Governments State Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) Federal Government Eligible Agencies of the Federal Government U.S. Territory or Possession Other Independent School Districts Public Housing Authorities/Indian Housing Authorities Native American Tribal Organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations Non-domestic (non-U.S.) Entities (Organizations) GrantsInfo@nih.gov 01/08/2027 One-Time Grant No No No No No Federal
12 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM CancerX Startup Accelerator CancerX All Innovation CancerX Accelerator is the first-ever innovation accelerator to focus at the intersection of digital innovation and cancer. It uniquely brings together a community of champions, innovators, and users of digital health in oncology to generate and scale ideas that have the potential to solve unmet needs in clinical delivery for cancer patients and providers. Every fall, submissions open for the next Accelerator cohort, and a panel of esteemed CancerX Champions and judges conduct several rounds of judging during winter to select the startup finalists. Not Specified hello@cancerx.health Recurring Accelerator Individuals Yes No No Yes Not Specified Private
13 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Capital Investment Tax Credit Florida Department of Revenue All Innovation The credit is for capital-intensive industries operating in a designated high-impact portion of the following sectors in Florida: advanced manufacturing, clean energy, financial services, life sciences, information technology, transportation, semiconductors, or a corporate headquarters facility. Annual credit, provided for up to 20 years, against the corporate income or premium tax liability. Businesses must make a cumulative investment of at least $25 million and create a minimum of 100 new full-time jobs Telephone: 850-617-8346 One-Time Tax Credit Organizations Yes No No No Yes State
14 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Carnegie Mellon University Venture Challenge Carnegie Mellon University All Innovation Student teams that compete at CMU VC are offered a unique value proposition: exposure, funding, and feedback. Early-stage companies require significant prototyping funds before a working product can materialize. In order to help teams grow from the experience, the CMU VC aims to objectively reward innovative teams with capital, services, and constructive feedback from experts in a variety of technical and legal domains. $5,000 Submissions should be submitted by an individual or a team of up to five members. The student Individuals pitching their startups at the CMU VC MUST be undergraduate students. Teams are allowed to have non-undergraduates, but the main founders must be undergraduates. Teams with member(s) taking a leave of absence are still eligible to participate. Teams must not have raised more than $500K USD in funding from institutional investors, angels, or competitions. Participants are NOT required to be Carnegie Mellon students. The CMU VC is open to any and all undergraduate students that are currently studying in the United States or Canada. Submissions should be the individual's or team's original work. Teams must pitch at the final round to receive any prizes for placing Top 12. anishac@andrew.cmu.edu Recurring Pitch Competition Students No No No Yes Yes Private
15 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Cigna Ventures Cigna All Innovation The Cigna Group Ventures is the strategic venture fund of The Cigna Group. Cigna Ventures seeks to be the strategic venture capital partner of choice and focuses on finding and partnering with heath care startups as they look to become a catalyst for bold new opportunities to make health care more affordable, simple, and predictable. Investments are focused on maximizing impact across three areas of focus: 1. Data and technology 2. Digital health 3. Care delivery Other: Contact Us Page on Website Recurring Equity Financing Individuals No No No No Not Specified Private
16 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Bioengineering Research Grants National Institutes of Health Scientific Research The goal for a bioengineering research grant (BRG) is to foster the development of an innovative technology, model, technique, design, or method that has the potential for a significant impact on biomedical research by infusing principles and concepts from the quantitative sciences. The purpose of this NOFO is to encourage BRG applications that: 1) apply a multidisciplinary approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods, and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. A BRG application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical, or translational science. To reduce cancer risk, incidence, morbidity, and mortality and enhance quality of life in cancer survivors through an orderly sequence from research on interventions and their impact in defined populations to the broad, systematic application of the research results through dissemination and diffusion strategies. Primary emphasis is on the inclusion of cancer prevention and control intervention(s) in any proposed study. up to $500,000 Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the How to Apply-Application Guide. bioengineeringresearchgrants@mail.nih.gov 07/06/2029 Grant No Ni No No Federal
17 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Concept to Clinic: Commercializing Innovation (C3i) Program - Acceleration National Institutes of Health All Innovation Acceleration: The C3i Accell program provides product development and business support to assist academic innovators in accelerating the translation of their biomedical technologies. The primary objective is to complete proof-of-concept studies and facilitate preparations for commercialization through start-up formation, strategic partnership, or out-licensing. It is expected that Project Teams forming start-up companies will be well-positioned to compete for NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants to further commercial development efforts. $100,000 The C3i program is being offered to investigators who have active NIH-funded research projects from participating Institutes and Centers and who have recently completed the core C3i Program. Eligible investigators may submit administrative supplement requests to advance technology development and translational research aims consistent with the peer-reviewed objectives of the parent grant. Investigators may propose research and development efforts that incorporate the learnings from the C3i Program and take advantage of unanticipated opportunities to increase the value of the project. The National Institute of Biomedical Imaging and Bioengineering (NIBIB) will support active grant awards from research project (K99/R00, R01, U01, and P41) activity codes. NIBIB-SBIR@mail.nih.gov Recurring Grant Individuals No No No No Not Specified Federal
18 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Concept to Clinic: Commercializing Innovation (C3i) Program - Education National Institutes of Health All Innovation Education: The eC3i course offered is an online entrepreneurial education platform aimed at teaching academic innovators methods to assess the commercial value of their biomedical technologies. The eC3i course is an online entrepreneurial education platform, covering 10-weeks and providing valuable business approaches to evaluating the commercial potential of promising biomedical technologies. Participants in the eC3i Program will learn an initial set of core skills that will enable them to: characterize the unmet market need, identify the key product attributes. conduct customer and stakeholder interviews, and validate the business opportunity The eC3i course is being offered to investigators with active NIH-funded research projects from participating Institutes and Centers. It is designed for medical device innovators who are interested learning how to assess if their project represents a compelling commercialization opportunity. It is recommended that participating Project Teams consist of at least two members: 1) inventor or technical lead, and 2) graduate student or post-doctoral candidate involved in the project. The inventor or technical lead has primary responsibility for achieving the technical success of the project. The technical lead should be the PD/PI for the parent award project, or a co-investigator, with in-depth knowledge of the technology or innovation. The graduate student or post-doctoral candidate should be an individual with a strong interest in investigating the commercial landscape surrounding the innovation and would be likely to pursue an entrepreneurial role if a company were to be formed. Project Team members are not required to be key personnel on the parent award project. NIBIB-SBIR@mail.nih.gov Recurring Grant Individuals No No No Yes Not Specified Federal
19 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Concept to Clinic: Commercializing Innovation (C3i) Program - Validation & Execution National Institutes of Health All Innovation Validation & Execution: The C3i Program is an in-depth, entrepreneurial training experience designed to help biomedical innovators validate a market need and viable business opportunity, along with developing a compelling pitch for prospective investors and partners. The C3i Program is a 24-week entrepreneurial training course, divided into two 12-week phases, and consists of one in-person event, weekly teleconferences, lectures, and coursework. Participants in the C3i Program will develop a comprehensive set of core skills that will enable them to: evaluate whether a compelling unmet market need exists for their proposed solution assess whether there is a viable business opportunity that can be built to meet this need build a compelling pitch presentation to secure support from potential investors and other business partners The C3i Program is being offered to investigators with active NIH-funded research projects from participating Institutes and Centers. It is designed for medical device innovators who are interested in understanding whether they have a compelling commercialization opportunity and how they can package this opportunity to interest investors and/or business partners. Much of the course is dedicated to validating the basis for further investment of time, energy, and money by the Project Team and future business partners. Project Teams are pushed to question and challenge the fundamental assumptions and basis for the 'business hypothesis' they are trying to validate during the Program. It is strongly recommended that Project Teams consist of at least two members: 1) Inventor or Technical Lead, and 2) Business Lead. The Inventor or Technical Lead has primary responsibility for achieving the technical success of the project. The Technical Lead should be the PD/PI for the parent award project, or a co-investigator, with in-depth knowledge of the technology or innovation. The Business Lead has primary responsibility for guiding the overall business development and commercialization strategy for the project. For existing companies, the Business Lead should be the Chief Executive Office (CEO) or other C-level officer (e.g. Chief Technology Officer or Chief Operating Officer). For academic teams, the Business Lead should be an individual with a deep commitment to investigate the commercial landscape surrounding the innovation and would be most likely to take on the role of CEO if a company were to be formed. In the scenario in which the Technical Lead (PD/PI) might also serve as the Business Lead (CEO) for the project, applicants are encouraged to consider identifying an additional Project Team member with considerable commitment to the project. Project Team members are not required to be key personnel on the parent award project. NIBIB-SBIR@mail.nih.gov Recurring Grant Individuals No No No Yes Yes Federal
20 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 03:24 PM CVS Health® Ventures CVS Health All Innovation Venture capital investment platform driving health care innovation and digital disruption forward. CVS Health Ventures works with high-potential startups that aim to make health care simpler, more accessible and affordable. Four key investment areas:
1. Transforming Care Delivery
2. Whole person care
3. Consumer-centric health
4. Disruptive technology enablement		 Recurring Equity Financing Individuals No No No Yes Not Specified Private
21 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Dr. and Mrs. Alfonse and Kathleen Cinotti Health Care Screening and Services Grant Program (RFA under development) Florida Department of Health Access to Care The Dr. and Mrs. Alfonse and Kathleen Cinotti Health Care Screening and Services Grant Program (Cinotti Grant Program) funds the provision of no-cost health care screenings or services for the general public by nonprofit entities. A nonprofit entity may apply for grant funding to implement a new health care screening or service program or to provide the same or similar screening that it is currently providing in new locations or through a mobile health clinic or mobile unit to expand the program’s delivery capabilities. Grant funding must be spent on screenings, including referrals for treatment, if appropriate, or related services for one or more of the following: Cancer Chronic obstructive pulmonary disease Dental Diabetes Hearing Hearth disease Hypertension Renal Disease Scoliosis Stroke Vision Telephone: 850-245-4009 Forecasted Grant Yes Yes No No Not Specified State
22 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM E-Fest Schulze School of Individualship All Innovation e-Fest® is delivered in partnership with the Schulze School of Individualship and EIX.org, a non-profit online platform for Individualship education. e-Fest is a three-day event that brings together the top 25 teams from a national pool of online business plan submissions. e-Fest features four competitions, professional development workshops, presentations from prominent business leaders, and a keynote presentation delivered by Richard M. Schulze, the benefactor of e-Fest and the founder and chairman emeritus of Best Buy. $10,000 Student Involvement: The competition is for student-created and student-managed ventures, including new ventures launched by licensing university technology. Students are expected to: Be advised by a current undergraduate student faculty member or Individualship center director from a 4-year college or university in North America. Play the primary role in developing and leading the business. Have key management roles in the venture. Have fundamental, equity-holding (or potential equity-holding) positions within the company and have a combined ownership/potential ownership of at least 25% of the founder's equity in the company. Be part of only one e-Fest team (students may be a part of multiple e-Fest teams during the online submission round but can only compete at the e-Fest Finals on one team.) Be present during the entire competition and at the time of the prize presentations to be eligible for prizes. jgessner@stthomas.edu Recurring Pitch Competition Students No No No Yes Yes Private
23 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Empowered to Serve Business Accelerator - AHA American Heart Association All Innovation The six-week National Empowered to Serve Business Accelerator is an intensive training and grant program to help the applicant scale their health impact-focused business within a condensed timeframe. Despite its short duration, the accelerator challenges the applicant to evolve their business model, accelerate the progress to scale and craft a compelling brand story to take the fundraising to the next level. Up to $75,000 The following are eligible to apply: 1. Non-profits 2. For-profits: Pre-seed through Series A 3. US citizens 18 years or older 4. Must address one or more categories of the Social Determinants of Health 5. Innovation must apply to improving health inequities 6. Must be available during crucial accelerator dates 7. Types of companies eligible for consideration: Healthtech, MedTech, social impact, innovative community centered solution 8. Companies not eligible: health supplements, gyms, spas or personal trainers, private medical practice, and food related companies- smoothies, shakes, and other prepared food items that do not fall under the AHA guidelines. apply@heart.org Recurring Accelerator Individuals No No No Yes Yes Private
24 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Endeavor Lab Endeavor Miami All Innovation A cohort based program to support underrepresented founders in Florida in building a foundation of scale. Endeavor selects up to 10 companies following its global selection criteria for high-impact Individuals. Through curated and personal exchanges with fellow cohort members, founders get to create new relationships and meaningful local support system. 1. Entrepreneur: An ambitious entrepreneur who aspires to take their business to the next level and understands the power of community in the success of an entrepreneur's journey. 2. Business Model: Endeavor looks for Individuals building businesses with unique, scalable, innovative, and potentially disruptive business models. They select companies with a strong value proposition that have the potential to be category leaders globally. 3. Operations: The founder and the company are based in Florida, contributing to the growth of its local economy. 4. Stage of Growth: For EndeavorLAB, Endeavor selects companies that are in the early stages of commercialization and that are generating revenue from non-pilot paying customers. An ideal candidate has a product that is live and operational. Lastly, even if the company has not yet cemented its Product Market Fit, founders are actively working towards it. 5. The entrepreneur must be a founder, the company must have product-market fit and be generating between $50K and $500K in annual revenues. All industries are welcome to apply as long as the solution is not service-based. Endeavor does not work with consulting firms, marketing agencies, event planning agencies, financial firms and other service-based companies. Participation Cost: A scholarship will be provided by the cohort sponsor on behalf of each founder to cover participation costs. Endeavor Lab's curriculum is tactical. Founders select members to help them navigate challenge areas and identify potential solutions to be implemented immediately with real-time feedback. Founders receive neutral this-party support from full-time account managers. Content Delivery: Participants will take part in 5 weeks of group modules and 1-1 mentorship on gearing up for scale. Closing event: Founders will pitch to the Endeavor community for brand exposure, strategic connections and pitch practice. Commitment: EndeavorLAB participants meet every Thursday from 10am to 1pm. In addition, participant will meet with their mentor for one hour up to three times. Most of EndeavorLAB will take place virtually, except the Launch Event, Cohort Retreat, Module 3 and the Closing Event which will take place in person in the Miami area. 2024 Cohorts: Latinx Founders (deadline January 21st), Black Founders (deadline May 3rd) and Women Founders (deadline August 23rd) miamiprograms@endeavor.org Recurring Accelerator Individuals Yes No No Yes Not Specified Private
25 elizabethlevenstein 07/09/2026 02:59 PM elizabethlevenstein 07/09/2026 02:59 PM Florida Development Finance Corporation Florida Development Finance Corp. All Innovation Designated as a state-wide, special development financing authority (bond agency) for economic development purposes. Its purpose is to assist new and existing businesses and organizations (for-profit and not-for-profit) with access to capital through financings that promote business activity, job creation, and an improved standard of living for the citizens of Florida. Be a US-based company. Be registered to do business in Florida. Be able to meet a minimum of 3 years of operating history Be designated as a Nonprofit 501(c) (3) status by the Internal Revenue Service Charitable Organizations Food Banks Community Programs Organizations Hospitals Assisted Living Facilities Urgent Care Centers Educational Organizations Private Schools Charter Schools Research Institutions Recreational Organizations Veteran Support Centers Community Centers Museums Art Galleries Youth Clubs info@fdfcbonds.com Recurring Bond Yes Yes No No Yes State
Focus Area Funding Cycle Funding Mechanism Eligible Recipients Florida Resident Required Nonprofit Required Small Business Required Early Stage Funding U.S. Ownership Required Type of Funding